glp-1 approved for sleep apnea Survey: Providers Want GLP-1s Did You Know? The FDA
Description
Similarly, this latter analysis, which covered nearly 2.25 million patients, did not show an excess risk of suicidal ideation and behavior in patients taking GLP-1s
GIP is a hormone released by the gut that stimulates the release of insulin to regulate blood sugar levels and metabolism (how our bodies burn food for energy)
In a recent meta-analysis which included data from six randomised control trials involving 3,484 patients, tirzepatide showed impressive glycaemic efficacy and weight loss data over 1 year of use
467 Among patients with moderately to severely active UC, 40.6% of patients treated with tofacitinib (10 mg twice daily) for 8 weeks achieved significant remission
ColonBroom aims to empower individuals seeking non-prescription wellness alternatives through transparent ingredient disclosures and evidence-aligned messaging
